ArticleFrontiers in medicine2026
Construction and validation of explainable machine learning models to predict in-hospital mortality for patients with acute type A aortic dissection surgery.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To construct and validate a risk prediction model of in-hospital mortality using machine learning (ML) algorithm in a retrospective cohort of acute type A aortic dissection (ATAAD) patients undergoing surgical treatment. Methods: Patients with ATAAD undergoing surgical treatment between January 2014 and December 2022 were enrolled to predict in-hospital mortality. To address class imbalance and overfitting, we developed a robust Random Forest (RF)-based classification framework using a nested stratified 5-fold cross-validation (NCV). This was a single-center, retrospective study with internal validation only; no external validation was performed. Performance was evaluated via ROC-AUC, Precision-Recall Area Under the Curve (PR-AUC), sensitivity, brier score and calibration metrics, with Shapley Additive exPlanations (SHAP) utilized for feature interpretation. Results: A total of 639 ATAAD patients were included in the analytical cohort, with an in-hospital mortality rate of 5.6% (36/639). The calibrated full RF model (50 preoperative clinical variables) achieved an ROC-AUC of 0.666, PR-AUC of 0.145, brier score of 0.051, and calibration slope of 0.836, with a sensitivity of 0.694 at an optimized threshold. A parsimonious 15-feature model maintained robust performance (ROC-AUC: 0.752, PR-AUC: 0.207, brier score: 0.050 and calibration slope: 0.934). SHAP analysis identified Creatine Kinase-MB, Myoglobin, and Fibrinogen Concentration as the top mortality predictors. Conclusion: We developed and internally validated an explainable RF model to predict in-hospital mortality after ATAAD surgery. Given the low positive predictive value and high negative predictive value, the model is best regarded as a promising preliminary rule-out/triage tool that requires multicenter external validation before clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.